Natural Products Targeting Autophagy via the PI3K/Akt/mTOR Pathway as Anticancer Agents

ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)

Volume 16, 12 Issues, 2016

Download PDF Flyer

Anti-Cancer Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 27th of 59 in Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

Michelle Prudhomme
Universite Blaise Pascal - C.N.R.S
Aubiere Cedex

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.722
5 - Year: 2.849

Natural Products Targeting Autophagy via the PI3K/Akt/mTOR Pathway as Anticancer Agents

Anti-Cancer Agents in Medicinal Chemistry, 13(7): 1048-1056.

Author(s): Hui Sun, Zhaoye Wang and Juan Sebastian Yakisich.

Affiliation: Department of Clinical Neuroscience R54, Karolinska University Hospital, Stockholm, Sweden, S-141 86.


The phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway is a key regulator of authophagy. Natural products show anticancer activity and often induce apoptosis or autophagy. The crosstalk between these two types of cell death makes autophagy an interesting target since drugs targeting this process not only can induce cell death by inducing autophagy but can also sensitize cells to apoptosis. Autophagy is also a protective mechanism associated with increased resistance to chemotherapy. In this review, we discuss natural products known to induce autophagy cell death in cancer cells via the PI3K/Akt/mTOR pathway.


Natural products, PI3K/Akt, autophagy, cancer stem cell, stemness, cell death, anticancer drugs.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 13
Issue Number: 7
First Page: 1048
Last Page: 1056
Page Count: 9
DOI: 10.2174/18715206113139990130
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science